|
 |
| ERRATUM |
|
| Year : 2015 | Volume
: 6
| Issue : 2 | Page : 122 |
|
|
Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study: Erratum
| Date of Web Publication | 20-Apr-2015 |
Correspondence Address:
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0976-500X.155497
How to cite this article:
. Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study: Erratum. J Pharmacol Pharmacother 2015;6:122 |
How to cite this URL:
. Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study: Erratum. J Pharmacol Pharmacother [serial online] 2015 [cited 2021 Jan 23];6:122. Available from: http://www.jpharmacol.com/text.asp?2015/6/2/122/155497 |
Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study: Erratum
In the article, "Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study", which appeared in vol. 6, issue 1, pages 30-33 of Journal of Pharmacology and Pharmacotherapeutics, [1] the abbreviation in [Table 1], at page 31, is incorrectly written as CTACE instead of CTCAE for the expansion of Common Terminology Criteria for Adverse Events.
This has now been corrected and reposted online.
 References | |  |
| 1. | Francis J, Palaniappan M, Dubashi B, Pradhan SC, Chandrasekaran A. Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study. J Pharmacol Pharmacother 2015;6:30-3.  [ PUBMED]  |
|
